September 2013 FDA Recall Drug by Osmotica Pharmaceutical Corp
D-1067-2013 - Failed Dissolution Specification

This Class III drug recall was voluntarily initiated by Osmotica Pharmaceutical Corp on September 16, 2013 for the product Drug. The FDA reported the reason for recall as failed dissolution specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1067-2013

Reason for Recall
Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.
Initiated
09-16-2013
Reported
10-09-2013
Quantity
57857 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Osmotica Pharmaceutical Corp
Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.

Batch or Lot Expiration Information

Lot# : a) 58975, 58976, 58977, 65165 , Exp 01/14; b) 58973, 58974, 65131, Exp: 01/14